School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

PTC Therapeutics, Inc. PTCT

Healthcare · Biotechnology

$64.70last close 2026-10-09 · market cap $5.40B · delayed data

Trailing returns

1M-4.25%
3M-27.75%
6M-8.68%
1Y-1.98%

Basis: Adjusted daily closes.

What it does

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Open PTCT in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies